Sodium Acetate

DRUG2 trials

Sponsors

Ultragenyx Pharmaceutical Inc, University of Colorado, Denver

Conditions

Alcohol AbstinenceAlcohol Use DisorderAlcohol WithdrawalOTC Deficiency

Phase 1

Intravenous Acetate as an Adjunctive Treatment for Alcohol Withdrawal in Hospitalized Patients

Not yet recruitingNCT07810946

University of Colorado, DenverAlcohol Withdrawal, Alcohol Abstinence, Alcohol Use Disorder

Start: 2026-09-01End: 2029-06-30Target: 75Updated: 2026-09-09

Phase 3

Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency

Active, not recruitingNCT05345171

Ultragenyx Pharmaceutical IncOTC Deficiency

Start: 2022-10-18End: 2031-03-01Updated: 2026-09-09

Related Papers

A retrograde approach for liver gene transfer

Molecular Therapy — Methods & Clinical Development2022-11-251 citations